VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $15,526,000 | +29.4% | 500,200 | -14.5% | 0.03% | +28.6% |
| Q1 2018 | $11,994,000 | -58.9% | 584,800 | -47.5% | 0.02% | -56.2% |
| Q4 2017 | $29,182,000 | +4576.6% | 1,113,800 | +2951.5% | 0.05% | +4700.0% |
| Q3 2017 | $624,000 | +3800.0% | 36,500 | +3135.8% | 0.00% | – |
| Q1 2017 | $16,000 | -93.0% | 1,128 | -86.7% | 0.00% | – |
| Q1 2016 | $230,000 | -76.4% | 8,504 | -8.6% | 0.00% | -100.0% |
| Q4 2015 | $976,000 | -89.5% | 9,304 | -77.3% | 0.00% | -90.0% |
| Q3 2015 | $9,258,000 | +342.5% | 41,004 | +340.7% | 0.02% | +400.0% |
| Q2 2015 | $2,092,000 | +1587.1% | 9,304 | +1760.8% | 0.00% | – |
| Q1 2015 | $124,000 | -100.0% | 500 | -94.0% | 0.00% | -100.0% |
| Q2 2013 | $717,993,000 | – | 8,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |